Materials and methods
Mouse Emi1 was amplified by PCR using a 13 dpc embryo cDNA library and
oligonucleotides 5′-AGGAATTCATGAAGTGTTTTAATTGCAACCCT G-3′ (forward) and
5′-GGTCGACTCACAATCTTTGTAAGTTCTTTTTA C-3′ (reverse) and subcloned into
the
EcoRI and
SalI sites of either pCDNA3-myc or pGEX4T1
expression vectors for myc- or GST-tagged Emi1, respectively.
Oligonucleotides were derived from the mouse Emi1 homologue deposited in
the NCBI database (Fbxo5: NM_025995). Additional oligonucleotides used
were as follows: 5-GGTCGACTCATAGGTGCTCCAGGCCCAT-3′ (reverse) for
GST-Emi1
1–181, 5′-AGGAATTCATGCAGCGAGTCATTGAAAGC-3′ (forward)
for Emi1
236–383, 5′-GGTCGACTCAGGCTTTGAGGCTTTCGTTG-3′
(reverse) for Emi1
236–313. Point mutations in Emi1 were
introduced by using mutated oligonucleotides and PCR amplification.
Pfu polymerase (Stratagene) was used for all amplifications and
constructs sequences were verified by direct sequencing. The vector
pMT2-HAp90
Rsk2 was a generous gift of Dr Mortin Frodin.
Expression and purification of GST fusion proteins Plasmids
(pGEX-) containing GST fusion proteins were transformed into the
Escherichia coli BL21 strain, and grown at 30°C in LB medium to an OD600=0.6
before induction with 0.5 mM isopropyl-β-thiogalactopyranoside (IPTG,
Sigma-Aldrich) for 3 h. GST fusion proteins were purified from bacterial
lysates on glutathione-agarose (Sigma-Aldrich) as previously described (Sette
et al, 1998) and analysed by SDS–PAGE and Coomassie blue
staining to test purity and integrity.
Cell culture and transfections Hek293 cells were maintained in
Dulbecco's medium supplemented with 10% fetal bovine serum (FBS) (Gibco
BRL) in 90 mm dishes. Subconfluent monolayers were processed for CaPO4
transfection with 1–10 μg of the appropriate plasmids or by Fugene
(Stratagene) with 0.2–2 μg of the appropriate plasmids as previously
described (Sette et al,
2002). At 24–48 h after transfection, cells were harvested in lysis
buffer (50 mM Hepes, pH 7.5, 75 mM NaCl, 10 mM β-glycerophosphate, 2 mM
EGTA, 15 mM MgCl2, 0.1 mM sodium orthovanadate, 1 mM DTT,
0.5% Triton X-100, protease inhibitor cocktail (Sigma-Aldrich)) and
incubated for 10 min on ice. Lysates were centrifuged for 10 min at 10
000 g at 4°C and used for further analysis. Protein
concentration was determined using a protein assay kit (Bio-Rad)
following the manufacturer's instructions.
FACS sorting Transfected cells were separated based on size
(forward scatter) and green fluorescence (GFP-positive) using a
FACSVantage cell sorter (Beckton and Dickinson). Purity of GFP-positive
and -negative populations was >98%. Sorted cells were used for Western
blot analysis as described below.
Pull-down assays Cell extracts (500 μg of total proteins) were
added to 2 μg of GST fusion protein adsorbed on glutathione-agarose
(Sigma-Aldrich) in 250 μl (final volume) of lysis buffer supplemented
with 0.05% bovine serum albumin (BSA). After incubation for 90 min at
4°C under constant shaking, beads were washed three times with lysis
buffer without Triton X-100, and absorbed proteins were eluted in SDS
sample buffer (62.5 mM Tris–HCl, pH 6.8, 10% glycerol, 2% (wt/vol) SDS,
0.7 M 2-mercaptoethanol and 0.0025% (wt/vol) bromophenol blue) and
resolved on a 10% SDS–PAGE for subsequent Western blot analysis.
Immunoprecipitation assay Cell extracts (500 μg of total
proteins) were incubated with 1 μg of anti-myc antibody for 2 h at 4°C
under constant shaking. Protein A–Sepharose or protein G–Sepharose
(Sigma-Aldrich) was preadsorbed with 0.05% BSA before incubation with
the immunocomplexes for an additional hour. Hence, beads were washed
three times with lysis buffer and absorbed proteins were eluted in SDS
sample buffer for Western blot analysis.
Kinase assays For p90Rsk2 assays, 1 μg of each
GST-Emi1 fusion protein was incubated at 30°C for 20 min with the
purified active form of the kinase (5 U, Upstate Biotechnology) in
reaction buffer: 50 mM Hepes, pH 7.4, 10 mM MgCl2, 1 mM EGTA,
1 mM DTT, 10 mM β-glycerophosphate, 0.5 mM NaVO4, 50 μM ATP
and 5 μCi of
32P-γ-ATP. In some experiments, GST fusion proteins were
phosphorylated while still bound to the GSH-agarose beads and at the end
of the incubation the kinases were washed by rinsing three times with an
excess of kinase buffer (without label) before using the proteins for
pull-down assays. H1 kinase assays were performed on cell extracts of
GFP-positive Hek293 cells as previously described (Bhatt
and Ferrell, 1999).
Western blot analysis Cell extracts or immunoprecipitated
proteins were diluted in SDS sample buffer as described above and boiled
for 5 min. For oocyte extracts, 300 metaphase II oocytes/sample were
collected and immediately frozen in sample buffer. After thawing,
oocytes were sonicated and boiled before loading. Proteins were
separated on 10% SDS–PAGE gels and transferred to polyvinylidene
fluoride Immobilon-P membranes (Millipore) using a semidry blotting
apparatus (Bio-Rad). The membranes were saturated with 5% nonfat dry
milk in PBS containing 0.1% Tween 20 for 1 h at room temperature, and
incubated with the following primary antibodies (1:1000 dilution)
overnight at 4°C: mouse anti-HA (for HA-p90Rsk2, from BabCO
Berkeley antibody company); rabbit anti-actin (Sigma-Aldrich); mouse
anti-Myc (for myc-Emi1); rabbit anti-Emi1 (Gentaur); goat anti-p90Rsk2,
rabbit anti-Cdc20, rabbit anti-cyclin A2, mouse anti-cyclin-B1. Primary
antibodies were all from SantaCruz Biotechnology, unless specified
otherwise. Secondary anti-mouse or anti-rabbit IgGs conjugated to
horseradish peroxidase (Amersham) were incubated with the membranes for
1 h at room temperature at a 1:10 000 dilution in PBS containing 0.1%
Tween 20. Immunostained bands were detected by chemiluminescent method
(SantaCruz Biotechnology).
Immunofluorescence analysis Oocytes were processed for
immunofluorescence analysis using anti-tubulin antibody (1:100,
Sigma-Aldrich) or anti-Emi1 antibody (1:200, Gentaur) or anti-p90Rsk2
antibody (1:200, SantaCruz Biotechnology) as previously documented (Sette
et al, 2002).